PROPOSED LAW PROHIBITS BOOTH RENTAL BY NAIL AND SKIN CARE PROFESSIONALS

Only hair service providers would be allowed to booth rent in California.

San Diego, California: Given the popularity of booth rental, the significant impact of last year’s California Supreme Court decision known as Dynamex on the beauty industry has been difficult to manage. When booth rental is no longer a legal business model, what options do beauty professionals have other than employment or salon ownership? Recent legislation authored by Assembly Member Lorena Gonzales, D-San Diego, would clarify the Dynamex decision and most important, exempt certain professions. However, as currently amended, the only workers in the beauty profession considered exempt would be: “A worker providing hairstyling or barbering services who has a booth rental permit and is free from direction or control both under the contract for the performance of the work and in fact” (AB 5). Because nail and skin care services are specifically excluded, workers who provide these services would be prohibited from working in a booth rental arrangement. If enacted, this law would disadvantage more than 220,000 licensed nail and skin care professionals, many of whom operate as independent businesses within a licensed salon environment. Jaime Schrabeck, Ph.D., licensed manicurist and owner of Precision Nails, an employee-based salon in Carmel, California, opposes the legislation unless amended to include all licensees of the Board of Barbering and Cosmetology. “Denying licensed manicurists, estheticians and electrologists the opportunity to booth rent based on their scope of practice would be discriminatory and likely unenforceable. By limiting the exemption, this bill ignores the fact that cosmetologists are licensed to perform nail and skin care services also. How can cosmetologists be considered both booth renters and employees when minute by minute they could be providing hair, nail and/or skin care services? Laws that affect BBC licensees must apply fairly and equally to all.” “Circumventing this population doesn’t fix the Dynamex problem,” according to Wendy Cochran, licensed esthetician and founder of the California Aesthetic Alliance, an advocacy organization representing California beauty licensees. “Salon owners will be at risk for labor violations and audits by the state, targeting them for significant financial jeopardy. To avoid this, salon owners will push us out of our rentals, disrupting and closing many small businesses.” Want to take action to protect our industry? Contact your state representatives directly by email, phone or social media: http://findyourrep.legislature.ca.gov/. For more information, visit the California Aesthetic Alliance Facebook page. About California Aesthetic Alliance: California Aesthetic Alliance was created to promote and partner California’s licensed beauty professionals with clients seeking the most qualified professionals in the field and to advocate for beauty professionals as they navigate the complicated state regulations. 

Getting a Spa Body Wrap? Here’s What to Expect!

Whether you want to cleanse your skin or take a break from reality, getting a body wrap is an excellent way to relax at the spa. A body wrap is a therapeutic treatment that can be personalized for your needs. It combines an exfoliant or a body masque of lotions and creams with thermal coverings or a cleansing shower. But how do you prepare for a spa body wrap and what is the process like? Let’s look at what you should expect along with the types of body wraps available.  

Types of Body Wraps

Herbal

An herbal body wrap uses herbs and spices as an exfoliant or mask. Your therapist might also apply herb-infused oils to hydrate the skin. For the best results, select an herbal treatment that suits your personal needs. Eucalyptus, for example, is excellent for soothing sore muscles.   

Honey

Honey is often used in calming body wraps. As a therapeutic treatment, honey nourishes and moisturizes the skin. It also has antibacterial and antioxidant benefits, making it ideal for soothing acne-prone and irritated skin.

Coffee

A coffee body wrap is formulated to enhance circulation and awaken the skin. It also helps shed dead skin cells, improving uneven skin tone and texture. Your skin will feel polished, refined and silky soft.

Collagen

Designed to repair and rebuild the skin, this anti-aging wrap uses a rich collagen-boosting formula. It helps restore the youthful radiance of aging skin.

Paraffin

Your therapist brushes melted paraffin wax on your body, and as the wax solidifies, it locks in moisture for an intense skin-softening effect. This restorative treatment is also used to relieve achy joints and muscles.

Mud

This detoxifying spa body wrap uses mud to cleanse and purify the pores. It promotes healthy, glowing skin that’s firm yet supple.

Clay

Often used in slimming body wraps, clay can absorb excess water and firm the skin. It also purifies by drawing out toxins. The wrap can be made with a variety of clays including red, green, pink, bentonite or rhassoul clay.

Cellulite

Your therapist applies a paste designed to strengthen collagen and firm the skin. The treatment will include a luxurious combination of nourishing ingredients such as seaweed, coffee, vitamin C and amino acids. Usually, cellulite body wraps focus on the thighs and buttocks.

Seaweed and Algae

A purifying seaweed or algae paste is used to help the skin release toxins and excess fluids. Some formulas may include essential oils and clay for added benefits. Seaweed and algae are also rich in antioxidants, vitamins and amino acids, all of which can improve skin texture and elasticity.

Now that you know what to expect with a body wrap, you can attend your appointment with confidence. We hope you enjoy the therapeutic benefits of your spa treatment!

COSMEDIX Global Director of Education to Host 20th Anniversary Celebration at International Esthetics, Cosmetics & Spa Conference (IECSC)

COSMEDIX professional skincare brand announces its 20th anniversary celebration will be held during the highly anticipated International Esthetics, Cosmetics & Spa Conference (IECSC) June 15-17, 2019 in Las Vegas, Nevada. During the three-day event, the brand will celebrate 20 years in business by hosting skincare professionals from all over the world and by giving them the opportunity to experience the brand’s clean, clinical and luxurious products through a combination of product exhibitions and cutting-edge master classes.

IECSC, a professional-level tradeshow that focuses on those who are in the spa industry is expected to host more than 600 exhibitors and more than 22,000 attendees comprised of salon and spa owners along with managers, estheticians, makeup artists, medical estheticians, plastic surgeons and wellness practitioners.

Ryan Christopher, Global Director of Education at COSMEDIX will lead the classes that include demonstrations on today’s most innovative treatments such as Lymphatic Drainage using a Rose Quartz facial roller; nanoneedling with COSMEDIX treatment serums; and microcurrent and radio frequency with the COSMEDIX ELITE RELIEF Soothing Peptide Gel.

Christopher states his excitement about seeing all of the professional esthetician supporters. “The IECSC Las Vegas is our biggest show of the year and I’m so excited to see all of our spa partners. We have two classes this year that will demonstrate the power of COSMEDIX alongside trending devices to truly show how advanced our formulas can be!”

The classes will be on Saturday and Sunday from 3:30pm until 5pm. No registration is required to attend as IECSC admission tickets gain professionals free access to the COSMEDIX classes. As a special bonus, the brand will be honoring Peel Kits and product specials to all attendees. For more information, visit iecsclasvegas.com

ASK THE EXPERT: FDA PUBLIC HEARING ON CBD, HOW YOU CAN MAKE A DIFFERENCE

On Friday May, 31st,

The FDA held a public hearing at the U.S Food and Drug Administrations White Oak Campus in Silver Spring Maryland. The topic of the hearing was, “The Food and Drug Administration’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds.”

I was a personal witness to over 200+ attendees who filled the seats, with the leading members of the FDA at the head of the room. The support was evident. As I took in the moment, I was inspired. The turnout, demonstrated people exercising their given right of democracy, in hopes to influence and support one of America’s fastest growing industries, the industry of Hemp and more specifically hemp-derived Cannabidiol (CBD).Following the recent passing of the 2018 Farm Bill, the U.S. Food and Drug Administration (FDA) released a statement declaring their intention to retain their authority to regulate ingestible and topical products, including those that contain hemp and hemp extracts like Cannabidiol (CBD). The Farm Bill deemed hemp and its extracts like CBD, legal at the federal level, while the FDA wants to ensure product manufacturers are not marketing CBD products as Foods, Dietary Supplements or making such claims that their CBD products will treat, cure or prevent disease. Although Hemp and its extracts, was officially removed from the Control Substances Act (CSA), defining it as a cultural commodity and no longer being classified as a controlled substance like its plant cousin Marijuana, ( as a result of the 2018 Farm Bill); the statements released by the FDA with intentions to retain their regulatory authority over CBD confused the industry abroad.

The hearing began at 8 am, with the oral comments from randomly selected industry related companies starting at 8:15 am. Over 100+ speakers voiced their agendas, opinions, and beliefs that catered to the questions the FDA submitted for the public’s response. The FDA board heard from people like Tory Spindle, with the Johns Hopkins University School of Medicine, to Johnathan Miller representing the U.S. Hemp Roundtable. Health professionals like Julian Wright in Science and Recreation to public safety officials, manufacturers and even patients receiving the FDA approved CBD drug, Epidiolex. A seemingly simple objective of allowing both CBD supplementation and pharmaceutical drug application was vastly demonstrated on this historical day, that there was and is still a lot of industry ground to cover.

The Facts-

Some of the highlights covered during the FDA hearing examined points like:

  1. There’s enough published science and anecdotal evidence to recognize the intended use of Hemp-derived CBD, providing both medical and supplemental value.
  2. There are 3 primary forms of CBD that may affect the body differently, influencing possible drug interactions and side effects. These CBD variations should be treated separately when addressing vulnerable populations and demographics such as the elderly, immunocompromised patients and or children.
  3. The 3 primary forms of CBD are CBD isolate, CBD full spectrum and CBD broad spectrum. Other forms include CBD Distillate and water-soluble CBD.
    1. CBD Isolate – the pure, crystalline powder that typically contains >95% CBD.
    2. CBD Full Spectrum (Hemp Oil)- The crude oil extracted from the grown, whole Hemp plants (not Hempseed) and includes cannabinoids (primarily CBD), terpenes, flavonoids, and other organic compounds, with .3% THC or less.
    3. CBD Broad Spectrum (Hemp Oil)- The crude oil extracted from the grown, whole Hemp plants (not Hempseed) and includes cannabinoids (primarily CBD), terpenes, flavonoids, and other organic compounds, with 0.0% THC.
  4.  Drug interactions, side effects, vulnerable populations, and dosing, pertaining to ingestible and topical products made with CBD isolate were concerns the FDA expressed. The research and public data aren’t significant enough to determine the clarity needed to establish future standards regarding CBD Isolate.
  5. THC milligram content(<.3%) in full spectrum CBD oil-based products is currently not being disclosed on many marketed products, while it has the potential to interact with various drugs and may cause unwanted side effects. There is not enough research or public data on safety in the long term use of products that contain .3% THC as it pertains to children, pregnant women, or nursing women.
  6. Using CBD products made from Broad Spectrum hemp oil eliminates many if not all of the previous concerns mentioned above, however, it is still not widely available to the mass manufacturing industries due to limited access within the technological advancement in the manufacturing of CBD oil. 
  7. The FDA is requesting more research and public data to better understand the differences in the variations of CBD material and their methods of consumption, such as inhalation, ingestion, transdermal and topical application. The Scientific data points out that the metabolism of CBD is determined by the material type, dosage and the method it is consumed.

How You Can Help- 

The FDA requested public testimonials and economic data from the companies present at the hearing. If you would like to share your testimonial(s) about hemp-derived Cannabidiol, I will be submitting a compilation to the FDA docket on June 24th, 2019. You may submit your testimonial anonymously or be named. Your participation will support and protect the continued public access to CBD as both a supplement and or in the circumstances of a medical prescription to treat disease. It will also help to serve as a guide of understanding to the FDA regarding, the daily human exposure of CBD, it’s designation as a generally regarded safe food ingredient and how various populations may benefit or should seek advice from their primary care provider.

“It takes one drop of water to cause a ripple, it takes a massive force of energy to make a wave. “

To submit your testimonial on the specified Testimonial Sheet please email support@cbdcaregarden.com with the Subject titled, “I Want to Help.” The testimonial sheet will then be emailed to you and included in the FDA public data docket.

Vanessa Marquez

CEO & Founder CBD Care Garden

vm@cbdcaregarden.com

Resources:

Kapala Clinic. Barcelona (2018). What is the Entourage Effect?

Russo, E.B (2011). Taming THC: British journal of pharmacology, 163(7) 1344-1364

Russo, E., & Guy, G.W. (2006). A tale of two cannabinoids: Medical Hypothesis, 66(2), 234-246.